Virtual Library

 x 
My Library Virtual Library FAQ

Start Your Search

  • WCLC 2016

    17th World Conference on Lung Cancer

    Access to all presentations that occur during the 17th World Conference on Lung Cancer in Vienna, Austria

    Presentation Date(s):  
    • Dec 4 - 7, 2016
    • Total Presentations: 2466

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    Presentations will be available 24 hours after their live presentation time

    IASLC Member Price: $0.00 USD
    Enter Virtual Meeting Access Code
Filter Results:

Show Only Available Presentations

  • +

    SC04 - EGFR Tyrosine Kinase Inhibitors: A Model for Successful Drug Development

    • Type: Science Session
    • Track: Chemotherapy/Targeted Therapy/Immunotherapy
    • Presentations: 5
    • Moderators:S. Thongprasert
    • Coordinates: 12/05/2016, 11:00 - 12:30, Hall C7
    • +

      SC04.04 - Liquid Biopsies for Dynamic Monitoring of EGFR Mutations in Lung Cancer

      12:00 - 12:20  |  Author(s): M. Schuler

      • Abstract

      Loading...

      Information from this presentation has been removed upon request of the author.

      Information from this presentation has been removed upon request of the author.

  • +

    ISS08 - A prIME Oncology Satellite Symposium Supported by Boehringer Ingelheim Pharma GmbH & Co. KG.: Reaching New Heights in the Management of Non-Small Cell Lung Cancer: Focus in EGFR-Targeted Therapy

    • Type: Industry Supported Symposium
    • Track:
    • Presentations: 7
    • Moderators:M. Schuler
    • Coordinates: 12/05/2016, 17:45 - 19:15, Hall C7
    • +

      ISS08.01 - Welcome & Warm-up Quiz

      17:45 - 17:50  |  Author(s): M. Schuler

      • Abstract

      No abstract available for this presentation

    • +

      ISS08.02 - Key Decision Points for Personalized Patient Care of Advanced Non-Small Cell Lung Cancer (NSCLC)

      17:50 - 18:00  |  Author(s): M. Schuler

      • Abstract

      No abstract available for this presentation

    • +

      ISS08.03 - Managing EGFR–Mutant Adenocarcinoma: What is the Optimal First-Line Approach?

      18:00 - 18:20  |  Author(s): B. Melosky

      • Abstract

      No abstract available for this presentation

    • +

      ISS08.04 - Tackling Acquired Resistance to EGFR– Targeted Therapy: Evaluating Current and Emerging Treatment Strategies

      18:20 - 18:30  |  Author(s): K. Park

      • Abstract

      No abstract available for this presentation

    • +

      ISS08.05 - Contemporary Management of Squamous Cell Carcinoma: What is the Role of EGFR–Targeted Therapy in the Era of Immunotherapy?

      18:30 - 18:45  |  Author(s): M. Nicolson

      • Abstract

      No abstract available for this presentation

    • +

      ISS08.06 - Quiz Questions Revisited and Questions from the Audience

      18:45 - 19:00  |  Author(s): M. Schuler

      • Abstract

      No abstract available for this presentation

    • +

      ISS08.07 - prIME Points™

      19:00 - 19:05  |  Author(s): M. Schuler

      • Abstract

      No abstract available for this presentation

  • +

    P3.02b - Poster Session with Presenters Present

    • Type: Poster Presenters Present
    • Track: Advanced NSCLC
    • Presentations: 126
    • Coordinates: 12/07/2016, 14:30 - 15:45, Hall B (Poster Area)
    • +

      P3.02b-025 - Rapid and Highly Sensitive EGFRdelEx19 and KRAS Exon 2 Mutation Detection in EBUS-TBNA Specimen of Lung Adenocarcinoma

      14:30 - 14:30  |  Author(s): F. Oezkan

      • Abstract

      Loading...